NCT00047762View on ClinicalTrials.gov

Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Conditions
Colorectal Cancer
Interventions
DRUG

Erlotinib (aka Tarceva or OSI-774)

DRUG

Bevacizumab (aka Avastin or Rhu MAb VEGF)

Trial Locations (3)

46202

Indiana University Cancer Pavilion, Indianapolis

21231-1000

Johns Hopkins Oncology Center, Baltimore

75246-2006

Mary Crowley Medical Research Center, Dallas

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY